J Clin Med Res
Journal of Clinical Medicine Research, ISSN 1918-3003 print, 1918-3011 online, Open Access
Article copyright, the authors; Journal compilation copyright, J Clin Med Res and Elmer Press Inc
Journal website http://www.jocmr.org

Correction

Volume 8, Number 3, March 2016, pages 267-267


Correction: Efficacy and Safety of Ipragliflozin in Japanese Patients With Type 2 Diabetes: Interim Outcome of the ASSIGN-K Study

Takashi Iizukaa, Kotaro Iemitsua, Masahiro Takihataa, Masahiko Takaia, Shigeru Nakajimaa, Nobuaki Minamia, Shinichi Umezawaa, Akira Kanamoria, Hiroshi Takedaa, Takehiro Kawataa, Shogo Itoa, Taisuke Kikuchia, Hikaru Amemiyaa, Mizuki Kaneshiroa, Atsuko Mokuboa, Tetsuo Takumaa, Hideo Machimuraa, Keiji Tanakaa, Taro Asakuraa, Akira Kubotaa, Sachio Aoyagia, Kazuhiko Hoshinoa, Masashi Ishikawaa, Yoko Matsuzawaa, Mitsuo Obanaa, Nobuo Sasaia, Hideaki Kaneshigea, Fuyuki Minagawaa, Tatsuya Saitoa, Kazuaki Shinodaa, Masaaki Miyakawaa, Yasushi Tanakaa, b, Yasuo Terauchic, Ikuro Matsubaa, d

aStudy Group of the Diabetes Committee, Kanagawa Physicians Association, Kanagawa, Japan
bDivision of Metabolism and Endocrinology, Department of Internal Medicine, St. Marianna University School of Medicine, Kanagawa, Japan
cDepartment of Endocrinology and Diabetes, Yokohama City University Medical Center, Kanagawa, Japan
dCorresponding Author: Ikuro Matsuba, Matsuba Medical Clinic, 2-159 Tsukagoshi, Saiwai-ku, Kawasaki-shi, Kanagawa 212-0024, Japan

Manuscript accepted for publication January 20, 2016
Short title: Efficacy and Safety of Ipragliflozin
doi: http://dx.doi.org/10.14740/jocmr2417wc1

Corrections to article “Efficacy and Safety of Ipragliflozin in Japanese Patients With Type 2 Diabetes: Interim Outcome of the ASSIGN-K Study”, by Takashi Iizuka et al, published in Vol. 8, No. 2, 2016, p116-125, doi: http://dx.doi.org/10.14740/jocmr2417w

There were some errors in Table 2, the authors would like to make the following corrections.
The baseline postprandial blood glucose level (mg/dL) should read 199.1 ± 85.2, instead of 199.1 ± 1.49.
The 12 weeks postprandial blood glucose level (mg/dL) should read 154.9 ± 60.5, instead of 54.9 ± 60.5.



This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


Journal of Clinical Medicine Research is published by Elmer Press Inc.



 

 

 

 

Browse  Journals  

     

Journal of clinical Medicine Research

Journal of Endocrinology and Metabolism

Journal of Clinical Gynecology and Obstetrics

World Journal of Oncology

Gastroenterology Research

Journal of Hematology

Journal of Medical Cases

Journal of Current Surgery

Clinical Infection and Immunity

Cardiology Research

World Journal of Nephrology and Urology

Cellular and Molecular Medicine Research

Journal of Neurology Research

International Journal of Clinical Pediatrics

 

 

 

 

 

Journal of Clinical Medicine Research, monthly, ISSN 1918-3003 (print), 1918-3011 (online), published by Elmer Press Inc.            
The content of this site is intended for health care professionals.
This is an open-access journal distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License, which permits unrestricted
non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Creative Commons Attribution license (Attribution-NonCommercial 4.0 International CC-BY-NC 4.0)


This journal follows the International Committee of Medical Journal Editors (ICMJE) recommendations for manuscripts submitted to biomedical journals,
the Committee on Publication Ethics (COPE) guidelines, and the Principles of Transparency and Best Practice in Scholarly Publishing.

website: www.jocmr.org   editorial contact: editor@jocmr.org
Address: 9225 Leslie Street, Suite 201, Richmond Hill, Ontario, L4B 3H6, Canada

© Elmer Press Inc. All Rights Reserved.